CHINA HEALTH GROUP INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.119 HKD | -0.83% |
|
+9.17% | -13.77% |
| 03-26 | China Health Group Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 03-12 | China Health Group Inc. Announces Directorate Changes | CI |
| Sales 2021 | 83.6M 11.54M 90.32M 924M | Sales 2022 | 13.09M 1.81M 14.14M 145M | Capitalization | 255M 35.18M 275M 2.82B |
|---|---|---|---|---|---|
| Net income 2021 | 36M 4.97M 38.9M 398M | Net income 2022 | -15M -2.07M -16.21M -166M | EV / Sales 2021 | 3.53 x |
| Net cash position 2021 | 17.02M 2.35M 18.39M 188M | Net cash position 2022 | 12.07M 1.67M 13.04M 133M | EV / Sales 2022 | 18.6 x |
| P/E ratio 2021 |
8.6
x | P/E ratio 2022 |
-16.1
x | Employees | - |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 29.02% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -0.83% | ||
| 1 week | +9.17% | ||
| Current month | -9.16% | ||
| 1 month | -9.16% | ||
| 3 months | -27.88% | ||
| 6 months | -24.20% | ||
| Current year | -13.77% |
1 week
0.11
0.12
1 month
0.090.13
Current year
0.090.18
1 year
0.090.22
3 years
0.090.53
5 years
0.083.91
10 years
0.083.91
| Managers | Title | Age | Since |
|---|---|---|---|
Xia Guo
FOU | Founder | 58 | 31/12/98 |
Xue Mei Song
CMP | Compliance Officer | 56 | 31/01/00 |
Tsz Ngo Yu
SEC | Corporate Secretary | 38 | 31/08/22 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Xia Guo
FOU | Founder | 58 | 31/12/98 |
Xue Mei Song
CMP | Compliance Officer | 56 | 31/01/00 |
Bin Hui Ni
BRD | Director/Board Member | 64 | 30/03/15 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 0.119 | -0.83% | 20,000 |
| 25/04/24 | 0.12 | +10.09% | 620,000 |
| 24/04/24 | 0.109 | 0.00% | 0 |
| 23/04/24 | 0.109 | 0.00% | 0 |
| 22/04/24 | 0.109 | 0.00% | 0 |
Delayed Quote Hong Kong S.E., April 26, 2024 at 09:08 am
More quotes
China Health Group Inc. is a Hong Kong-based investment holding company principally engaged in the provision of terminal medical services. The Company provides hospital clinical research and product promotion services, hospital management services, mobile telemedicine services, special expertise therapy services and rehabilitation and medical tours services. Its clinical research services include Phase I clinical and bioequivalence studies, Phase IV post-marketing clinical study, data management and medical statistics and medical administration-related services, among others. Its hospital management services include Internet healthcare services and drug delivery services, such as Chinese best doctor and My doctor 999, among others.
Calendar
14/05/2024
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -13.77% | 15.13M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
- Stock Market
- Equities
- 8225 Stock
